Prot #CMP-001-010: A Multicenter, Open-label, Phase 2 Study of Intratumoral CMP-001 in Combination with Intravenous Nivolumab in Subjects with Refractory Unresectable or Metastatic Melanoma

Project: Research project

Project Details

StatusActive
Effective start/end date6/2/216/2/24

Funding

  • Novella Clinical, LLC (Prot #CMP-001-010)
  • Checkmate Pharmaceuticals, Inc. (Prot #CMP-001-010)